KNIGHT CAPITOL CONSULTANTS for INDIVIOR, INC.
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
Funding for opioid overuse treatment activities for FY 2020 (Further Consolidated Appropriations Act PL 116-94)
| Lobbyist | Covered position, as disclosed |
|---|---|
| PATRICIA KNIGHT | Chief of Staff, Senator Orrin G. Hatch |
Alcohol and Drug Abuse ALC
Implementation of the Support for Patients and Communities Act (P.L. 115-271); funding levels and distribution of funding for treatment of opioid overuse disorder (OUD) (Further Consolidated Appropriations Act, PL 116-94) promote awareness of medication assisted treatment/treatment of OUD with long-acting injectable products (no specific legislation).
| Lobbyist | Covered position, as disclosed |
|---|---|
| PATRICIA KNIGHT | Chief of Staff, Senator Orrin G. Hatch |
Health Issues HCR
DEA implementation of the SECURE Act and specifically Section 3204 addressing specialty pharmacy delivery to the provider of long-acting injectable buprenorphine products.
| Lobbyist | Covered position, as disclosed |
|---|---|
| PATRICIA KNIGHT | Chief of Staff, Senator Orrin G. Hatch |
Medicare/Medicaid MMM
Omnibus legislation affecting prescription drug pricing (Senate HELP -Lower Healthcare Costs Act (S. 1895), Senate Finance - S. 2543, Prescription Drug Pricing Reduction Act (PDPRA) of 2019 and H.R. 3, Lower Drug Costs Now Act of 2019.
| Lobbyist | Covered position, as disclosed |
|---|---|
| PATRICIA KNIGHT | Chief of Staff, Senator Orrin G. Hatch (1999-2007) |
Support LegiList
This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.